Join Growin Stock Community!

皇將4744.TW Overview

TW StockBiotech. & Medical
(No presentation for 4744)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

皇將（4744）Overall Performance

皇將（4744）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

皇將（4744） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

皇將（4744）Key Information

皇將（4744）Profile

CVC Technologies Inc. manufactures and sells various types of pharmaceutical packaging machines worldwide. The company offer tablet counting machines, such as bottle unscrambler and air rinser; tablet/capsule counter and filler; desiccant inserter; cotton/foam inserter; capper which includes chuck, rotary, vial, in-line, and vibratory press capper; induction cap sealer; shrink bundler and tunnel; intermittent cartoner; and track and trace machines. It also provides labeling machines, including top/bottom/side labelers, wrap-around labelers, front and back labelers, leaflet topserters, shrink sleeve applicators, and labeler inspection systems; liquid and powder filling machines, such as bottle unscrambler and air rinsers, liquid filler and cappers, capper machines, induction capsealers, labeling machines, and cartoner/shrink machines; encapsulation machines; auxiliary equipment, including jet masters, capsule printing machines, paste making systems, gelatin melting tanks, medicine preparation systems, drying systems, gelatin reclaim systems, and capsule inspection machines; and aluminum foil sealing machines, as well as semi-auto tablet/capsule counter. In addition, it offers packaging line design, factory acceptance testing, technical phone support, and field service and preventative maintenance services, as well as installation, startup, and training services. The company was founded in 1979 and is headquartered in Taichung, Taiwan.

皇將（4744）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
12.21
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
44.04%
Net Margin
8.02%
Revenue Growth (YoY)
15.22%
Profit Growth (YoY)
13.96%
3-Year Revenue Growth
8.44%
3-Year Profit Growth
11.02%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
12.21
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
44.04%
Net Margin
8.02%
Revenue Growth (YoY)
15.22%
Profit Growth (YoY)
13.96%
3-Year Revenue Growth
8.44%
3-Year Profit Growth
11.02%
default symbol

4744

皇將

31.70D

-1.26%

(-0.01)

  • When is 4744's latest earnings report released?

    The most recent financial report for 皇將 (4744) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4744's short-term business performance and financial health. For the latest updates on 4744's earnings releases, visit this page regularly.

  • Where does 4744 fall in the P/E River chart?

    According to historical valuation range analysis, 皇將 (4744)'s current price-to-earnings (P/E) ratio is 10.8, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 4744?

    According to the latest financial report, 皇將 (4744) reported an Operating Profit of 3.83M with an Operating Margin of 1.53% this period, representing a growth of 136.88% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4744's revenue growth?

    In the latest financial report, 皇將 (4744) announced revenue of 250.06M, with a Year-Over-Year growth rate of 7%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4744 have?

    At the end of the period, 皇將 (4744) held Total Cash and Cash Equivalents of 447.08M, accounting for 0.21 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4744 go with three margins increasing?

    In the latest report, 皇將 (4744) achieved the “three margins increasing” benchmark, with a gross margin of 46.1%%, operating margin of 1.53%%, and net margin of 7.79%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4744's profit trajectory and future growth potential.

  • Is 4744's EPS continuing to grow?

    According to the past four quarterly reports, 皇將 (4744)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.36. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4744?

    皇將 (4744)'s Free Cash Flow (FCF) for the period is -15.98M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 363.18% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.